115.90
price down icon2.69%   -3.21
after-market After Hours: 115.90
loading

Neurocrine Biosciences Inc Stock (NBIX) Latest News

pulisher
04:01 AM

Neurocrine Biosciences Sets March Schedule for Crucial Investor PresentationsWhat's Coming? - StockTitan

04:01 AM
pulisher
01:20 AM

Endometriosis Pipeline Drugs Analysis Report: FDA Approvals, - openPR

01:20 AM
pulisher
Feb 23, 2025

Neurocrine Biosciences authorizes $500M share repurchase program - MSN

Feb 23, 2025
pulisher
Feb 21, 2025

Is Neurocrine Biosciences (NBIX) One of the Best Fast Growth Stock to Buy Right Now? - Insider Monkey

Feb 21, 2025
pulisher
Feb 21, 2025

Shareholders Can Be Confident That Neurocrine Biosciences' (NASDAQ:NBIX) Earnings Are High Quality - Simply Wall St

Feb 21, 2025
pulisher
Feb 21, 2025

Neurocrine Biosciences' (NASDAQ:NBIX) Performance Is Even Better Than Its Earnings Suggest - Yahoo Finance

Feb 21, 2025
pulisher
Feb 21, 2025

DSM Capital Partners LLC Has $127.30 Million Holdings in Neurocrine Biosciences, Inc. (NASDAQ:NBIX) - MarketBeat

Feb 21, 2025
pulisher
Feb 21, 2025

Neurocrine Biosciences, Inc. authorizes a Buyback Plan. -February 20, 2025 - Marketscreener.com

Feb 21, 2025
pulisher
Feb 21, 2025

Assessing Neurocrine Biosciences: Insights From 15 Financial Analysts - Benzinga

Feb 21, 2025
pulisher
Feb 21, 2025

Huntington's Disease Market Growth to Accelerate in Forecast - openPR

Feb 21, 2025
pulisher
Feb 21, 2025

Neurocrine Biosciences sets $500M share buyback plan By Investing.com - Investing.com South Africa

Feb 21, 2025
pulisher
Feb 21, 2025

Neurocrine Biosciences sets $500M share buyback plan - Investing.com India

Feb 21, 2025
pulisher
Feb 21, 2025

Neurocrine Biosciences Approves $500 Million Share Repurchase Program -February 21, 2025 at 08:19 am EST - Marketscreener.com

Feb 21, 2025
pulisher
Feb 21, 2025

Neurocrine Board Authorizes Share Repurchase ProgramQuick Facts - Nasdaq

Feb 21, 2025
pulisher
Feb 21, 2025

Neurocrine Biosciences (NBIX) Announces $500M Share Buyback - StreetInsider.com

Feb 21, 2025
pulisher
Feb 21, 2025

Can Neurocrine's New $500M Buyback Signal Even Stronger Growth Ahead? - StockTitan

Feb 21, 2025
pulisher
Feb 21, 2025

Leerink Partnrs Issues Optimistic Outlook for NBIX Earnings - MarketBeat

Feb 21, 2025
pulisher
Feb 21, 2025

Rice Hall James & Associates LLC Sells 6,785 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) - MarketBeat

Feb 21, 2025
pulisher
Feb 21, 2025

Neurocrine Biosciences (NASDAQ:NBIX) Downgraded to Buy Rating by StockNews.com - MarketBeat

Feb 21, 2025
pulisher
Feb 21, 2025

AlphaCentric Advisors LLC Sells 18,816 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) - MarketBeat

Feb 21, 2025
pulisher
Feb 20, 2025

Neurocrine Biosciences Board Of Directors Authorizes $500 Million Share Repurchase Program - Marketscreener.com

Feb 20, 2025
pulisher
Feb 20, 2025

Leerink Partnrs Has Pessimistic View of NBIX Q3 Earnings - MarketBeat

Feb 20, 2025
pulisher
Feb 20, 2025

Ieq Capital LLC Increases Holdings in Neurocrine Biosciences, Inc. (NASDAQ:NBIX) - MarketBeat

Feb 20, 2025
pulisher
Feb 19, 2025

Van ECK Associates Corp Buys 9,824 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) - MarketBeat

Feb 19, 2025
pulisher
Feb 19, 2025

New York State Teachers Retirement System Cuts Position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX) - MarketBeat

Feb 19, 2025
pulisher
Feb 19, 2025

Vontobel Holding Ltd. Has $1.15 Million Holdings in Neurocrine Biosciences, Inc. (NASDAQ:NBIX) - MarketBeat

Feb 19, 2025
pulisher
Feb 18, 2025

Matt Abernethy Sells 2,558 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Stock - MarketBeat

Feb 18, 2025
pulisher
Feb 18, 2025

Neurocrine (NBIX): Among Top Insider Stock Buys And Sells In January - Insider Monkey

Feb 18, 2025
pulisher
Feb 18, 2025

Neurocrine Biosciences chief legal officer sells $107,727 in stock - MSN

Feb 18, 2025
pulisher
Feb 18, 2025

Neurocrine Biosciences' chief corporate affairs officer sells shares worth $208,387 - MSN

Feb 18, 2025
pulisher
Feb 18, 2025

Neurocrine Biosciences CFO Matt Abernethy sells $115,908 in stock - MSN

Feb 18, 2025
pulisher
Feb 18, 2025

Neurocrine Biosciences' SWOT analysis: navigating growth amid market shifts By Investing.com - Investing.com Nigeria

Feb 18, 2025
pulisher
Feb 18, 2025

Neurocrine Biosciences' SWOT analysis: navigating growth amid market shifts - Investing.com

Feb 18, 2025
pulisher
Feb 18, 2025

Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Sees Large Drop in Short Interest - MarketBeat

Feb 18, 2025
pulisher
Feb 18, 2025

Stanley Laman Group Ltd. Increases Position in Neurocrine Biosciences, Inc. (NASDAQ:NBIX) - MarketBeat

Feb 18, 2025
pulisher
Feb 17, 2025

Neurocrine Biosciences CHRO sells shares worth $181,129 - MSN

Feb 17, 2025
pulisher
Feb 17, 2025

Insider Selling: Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Director Sells 5,844 Shares of Stock - MarketBeat

Feb 17, 2025
pulisher
Feb 17, 2025

Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Position Trimmed by Allspring Global Investments Holdings LLC - MarketBeat

Feb 17, 2025
pulisher
Feb 17, 2025

Julie Cooke Sells 1,551 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Stock - MarketBeat

Feb 17, 2025
pulisher
Feb 17, 2025

Neurocrine Biosciences chief legal officer sells $254,991 in stock - MSN

Feb 17, 2025
pulisher
Feb 17, 2025

Stifel maintains Neurocrine Bio stock target, positive on Takeda deal - MSN

Feb 17, 2025
pulisher
Feb 17, 2025

Savant Capital LLC Purchases Shares of 16,543 Neurocrine Biosciences, Inc. (NASDAQ:NBIX) - MarketBeat

Feb 17, 2025
pulisher
Feb 16, 2025

Neurocrine Biosciences, Inc. (NASDAQ:NBIX) CEO Kyle Gano Sells 980 Shares - MarketBeat

Feb 16, 2025
pulisher
Feb 16, 2025

Insider Selling: Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Director Sells 2,274 Shares of Stock - MarketBeat

Feb 16, 2025
pulisher
Feb 16, 2025

Neurocrine Biosciences chief scientific officer sells $336,238 in stock - MSN

Feb 16, 2025
pulisher
Feb 16, 2025

Neurocrine Biosciences, Inc. (NASDAQ:NBIX) Stock Position Cut by Fiera Capital Corp - MarketBeat

Feb 16, 2025
pulisher
Feb 16, 2025

Neurocrine Biosciences executive sells shares totaling $258,263 - MSN

Feb 16, 2025
pulisher
Feb 16, 2025

Neurocrine Biosciences chief commercial officer sells $251,426 in stock - MSN

Feb 16, 2025
pulisher
Feb 16, 2025

Neurocrine Biosciences director Sherwin sells $1.6m in stock - MSN

Feb 16, 2025
pulisher
Feb 15, 2025

Neurocrine Biosciences CEO sells shares for $298,907 By Investing.com - Investing.com Australia

Feb 15, 2025
pulisher
Feb 15, 2025

Neurocrine Biosciences chief corporate affairs officer sells $82,820 in stock - MSN

Feb 15, 2025
pulisher
Feb 15, 2025

Neurocrine Biosciences chief commercial officer sells $115,940 in stock - MSN

Feb 15, 2025
pulisher
Feb 15, 2025

Neurocrine Biosciences executive sells shares worth $82,792 - MSN

Feb 15, 2025
$128.58
price up icon 0.01%
$11.48
price up icon 0.79%
$34.93
price down icon 1.66%
$80.05
price up icon 1.39%
$10.70
price down icon 3.69%
Cap:     |  Volume (24h):